Intranasal Lidocaine Application Technique for Cluster Headache
For cluster headache, apply 4% lidocaine solution intranasally using 4 sprays to the nostril ipsilateral (same side) to the headache pain, targeting the sphenopalatine fossa region, with the patient's head in a reclined position.
Application Technique
The proper technique for intranasal lidocaine in cluster headache involves targeting the sphenopalatine fossa region, which is critical for achieving therapeutic effect 1. Based on the available evidence and general nasal drug administration principles:
Patient Positioning
- Lie supine with head extended back - position the patient lying down with the head tilted backward and slightly off the edge of the bed (similar to Mygind's position) 2
- Alternatively, the head can be kept upright with slight extension 2
- The chin should be elevated to allow optimal drug deposition
Administration Steps
- Gently blow nose before application to clear nasal passages 2
- Use 4% lidocaine solution (concentrations >4% should not be used) 3, 4
- Administer 4 sprays ipsilateral to the headache side (same side as the pain) 4
- Direct spray away from the nasal septum - aim toward the lateral nasal wall and posterior nasopharynx to reach the sphenopalatine fossa 2
- Additional 2 sprays may be given if initial response is inadequate 4
- Hold position for 30-60 seconds after administration 2
- Patient should breathe normally during application 2
Clinical Context and Efficacy
Important caveat: The evidence for intranasal lidocaine in cluster headache is limited and shows only marginal benefit. The 2024 VA/DoD guidelines state there is insufficient evidence to recommend for or against intranasal lidocaine for short-term treatment of headache 5. A 2002 guideline noted that "a defined role for intranasal lidocaine as abortive migraine therapy has yet to be established" due to inconsistent results 6.
Research shows mixed results:
- Only 27% of patients reported moderate relief and 27% mild relief, while 46% had no relief 4
- However, when properly targeting the sphenopalatine fossa, 4 of 5 patients obtained rapid relief 1
- Recent case series suggest potential benefit in trigeminal autonomic cephalalgias including cluster headache 7
Safety Considerations
Maximum dosing:
- Use 4% lidocaine solution maximum - higher concentrations should not be used 3
- Calculate maximum safe dose based on ideal body weight (not actual weight if obese) 8
- Standard maximum dose is 4.5 mg/kg without epinephrine 9
- Do not use lidocaine solutions containing vasoconstrictors (epinephrine/adrenaline) for intranasal application 3
Monitoring:
- Minimal side effects reported with intranasal application 4
- Watch for signs of local anesthetic toxicity: tingling of tongue/lips, light-headedness, tinnitus, slurred speech 8
- Document total dose administered 3
Alternative First-Line Treatments
Given the limited evidence for intranasal lidocaine, strongly consider first-line treatments with robust evidence:
- Subcutaneous sumatriptan 6 mg (strong recommendation) 5, 10
- Intranasal zolmitriptan 10 mg 5
- High-flow oxygen (100% at ≥12 L/min for 15 minutes) (strong recommendation) 10
Intranasal lidocaine may be considered as an adjunctive or alternative option when first-line treatments are contraindicated, unavailable, or ineffective, given its ease of administration and favorable safety profile 4.